Onabotulinumtoxin A is under clinical development by AbbVie and currently in Phase III for Myofascial Pain Syndrome (Chronic Myofascial Pain). According to GlobalData, Phase III drugs for Myofascial ...
Therapeutics are treatments used to alleviate or prevent a particular disease. Examples of therapeutics include drug therapy, medical devices, nutrition therapy and stem-cell therapies ...
Purpose Myofascial pain syndrome (MPS) is a chronic musculoskeletal pain syndrome. The purpose of this review is to describe the epidemiological and treatment evidence and to address the future ...
"Your shoulder hurts, but it could be driven by your right hip being tight." The results can be chronic pain and limits to mobility that can only be relieved through therapies targeted to restoring ...